Abstract
Lactic acid bacteria (LAB) are gaining importance due to their “generally recognized as safe” status, long-term use in food and beneficial, probiotic properties. They can acquire new, desirable traits by the incorporation of genes that allow the expression of heterologous proteins, and several patents and patent applications describe the use of recombinant LAB. We first focus on the available expression systems, their improvement towards “food-grade” status, and modes of regulating the expression. LAB have been used as vehicles for the delivery of proteins to the mucosal surfaces. Delivered proteins may interact with the immune system and have been shown to be effective, either as vaccines or as toleranceinducing, anti-allergy agents in mice. Proteins with biological functions that could be used in therapy have also been delivered. Delivery of interleukin 10 (IL-10) in Crohns disease, which was tested in a human phase I clinical trial and has proceeded to phase IIa, is the first example of use of recombinant LAB in humans. Another field of recombinant LAB application is metabolic engineering. Existing metabolic pathways have been modified to improve the properties of LAB as food fermentation starters, and heterologous metabolic enzymes have been introduced to LAB for the production of industrially relevant chemicals.
Keywords: Lactic acid bacteria, Lactococcus, Lactobacillus, recombinant protein, vaccine, allergen, antigen, expression, delivery, metabolic engineering
Recent Patents on Biotechnology
Title: Novel Applications of Recombinant Lactic Acid Bacteria in Therapy and in Metabolic Engineering
Volume: 3 Issue: 2
Author(s): Ales Berlec and Borut Strukelj
Affiliation:
Keywords: Lactic acid bacteria, Lactococcus, Lactobacillus, recombinant protein, vaccine, allergen, antigen, expression, delivery, metabolic engineering
Abstract: Lactic acid bacteria (LAB) are gaining importance due to their “generally recognized as safe” status, long-term use in food and beneficial, probiotic properties. They can acquire new, desirable traits by the incorporation of genes that allow the expression of heterologous proteins, and several patents and patent applications describe the use of recombinant LAB. We first focus on the available expression systems, their improvement towards “food-grade” status, and modes of regulating the expression. LAB have been used as vehicles for the delivery of proteins to the mucosal surfaces. Delivered proteins may interact with the immune system and have been shown to be effective, either as vaccines or as toleranceinducing, anti-allergy agents in mice. Proteins with biological functions that could be used in therapy have also been delivered. Delivery of interleukin 10 (IL-10) in Crohns disease, which was tested in a human phase I clinical trial and has proceeded to phase IIa, is the first example of use of recombinant LAB in humans. Another field of recombinant LAB application is metabolic engineering. Existing metabolic pathways have been modified to improve the properties of LAB as food fermentation starters, and heterologous metabolic enzymes have been introduced to LAB for the production of industrially relevant chemicals.
Export Options
About this article
Cite this article as:
Berlec Ales and Strukelj Borut, Novel Applications of Recombinant Lactic Acid Bacteria in Therapy and in Metabolic Engineering, Recent Patents on Biotechnology 2009; 3 (2) . https://dx.doi.org/10.2174/187220809788700175
DOI https://dx.doi.org/10.2174/187220809788700175 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy
CNS & Neurological Disorders - Drug Targets PET Tracers for Serotonin Receptors and Their Applications
Central Nervous System Agents in Medicinal Chemistry The Emerging Role of the Histamine H4 Receptor in Anti-inflammatory Therapy
Current Topics in Medicinal Chemistry Modulatory Effects of Peroxisome Proliferator-Activated Receptor-γ on CXCR3 Chemokines
Recent Patents on Inflammation & Allergy Drug Discovery Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier
Current Medicinal Chemistry Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery Single Nucleotide Polymorphisms (SNPs): History, Biotechnological Outlook and Practical Applications
Current Pharmacogenomics Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses
Recent Patents on Anti-Cancer Drug Discovery Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors
Current Medicinal Chemistry EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science Elastic Bilayer Vesicles of Flurbiprofen for Transdermal Delivery: Development and In-Vitro Characterization
Drug Delivery Letters Involvement of Leukotriene Pathway in the Pathogenesis of Ischemia- Reperfusion Injury and Septic and Non-Septic Shock
Current Vascular Pharmacology Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Delivery Systems for Antimicrobial Peptides and Proteins: Towards Optimization of Bioavailability and Targeting
Current Pharmaceutical Biotechnology Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential
Current Medicinal Chemistry Recent Advances in Sepsis Research: Novel Biomarkers and Therapeutic Targets
Current Medicinal Chemistry Cytochromes P450 in the Bioactivation of Chemicals
Current Topics in Medicinal Chemistry Neurotoxic and Neuroactive Compounds from Cnidaria: Five Decades of Research….and More
Central Nervous System Agents in Medicinal Chemistry